Market Cap 1.39B
Revenue (ttm) 201.61M
Net Income (ttm) 2.82M
EPS (ttm) N/A
PE Ratio 216.00
Forward PE 86.08
Profit Margin 1.40%
Debt to Equity Ratio 0.00
Volume 2,461,800
Avg Vol 1,217,788
Day's Range N/A - N/A
Shares Out 129.00M
Stochastic %K 69%
Beta 0.92
Analysts Hold
Price Target $10.08

Latest News on ENFN

Clearwater Analytics Finalizes Acquisition of Enfusion

Apr 21, 2025, 4:15 PM EDT - 2 days ago

Clearwater Analytics Finalizes Acquisition of Enfusion

CWAN


Enfusion Announces Fourth Quarter and Full Year 2024 Results

Mar 3, 2025, 4:05 PM EST - 7 weeks ago

Enfusion Announces Fourth Quarter and Full Year 2024 Results


Clearwater Analytics to acquire Enfusion in $1.5 bln deal

Jan 13, 2025, 6:40 AM EST - 3 months ago

Clearwater Analytics to acquire Enfusion in $1.5 bln deal

CWAN


Enfusion: Revenue Growth Should Start To Accelerate

Dec 24, 2024, 7:30 AM EST - 4 months ago

Enfusion: Revenue Growth Should Start To Accelerate


Enfusion To Present at Upcoming Investor Events

Nov 20, 2024, 4:15 PM EST - 5 months ago

Enfusion To Present at Upcoming Investor Events


Enfusion, Inc. (ENFN) Q3 2024 Earnings Call Transcript

Nov 4, 2024, 3:11 PM EST - 6 months ago

Enfusion, Inc. (ENFN) Q3 2024 Earnings Call Transcript


Enfusion Announces Third Quarter 2024 Results

Nov 4, 2024, 7:30 AM EST - 6 months ago

Enfusion Announces Third Quarter 2024 Results


Enfusion Announces Date of Third Quarter 2024 Results

Oct 3, 2024, 8:30 AM EDT - 7 months ago

Enfusion Announces Date of Third Quarter 2024 Results